Location of Index CRC Affects Chance of Second Cancer

This article originally appeared here.
Share this content:
Index CRC Tumor Site Impacts Increased CA Risk for Survivors
Index CRC Tumor Site Impacts Increased CA Risk for Survivors

(HealthDay News) -- The location of index colorectal cancer (CRC) affects the incidence of second cancer after CRC, according to a study published online July 15 in Cancer.

Amanda I. Phipps, Ph.D., M.P.H., from the Fred Hutchinson Cancer Research Center in Seattle, and colleagues utilized 12 Surveillance, Epidemiology, and End Results cancer registries to identify patients diagnosed with a first primary CRC between 1992 and 2009. Standardized incidence ratios (SIRs) were calculated by comparing the incidence of subsequent cancers in these patients versus the incidence in the general population.

The researchers found that, compared with the general population, the cancer incidence rates were significantly higher in individuals who had a previous CRC (SIR, 1.15). The greatest increased risk overall (SIR, 1.29 to 1.33) and with respect to the risk of a second CRC (SIR, 2.53 to 3.35) was seen in individuals with an index CRC located between the transverse and descending colon.

Regardless of the index CRC subsite, the incidence of small intestinal cancer was significantly increased (SIR, 4.31). For those with an index CRC in the proximal colon, the incidence of endometrial cancer was significantly elevated (SIR, 1.37 to 1.79).

"The results presented here confirm previous reports of an elevated cancer risk in CRC survivors relative to the general population and provide added evidence that this elevated risk differs by location of the index CRC," the authors write.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs